Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tirofiban (5mg) Infusion
Therapeutic Category
Anticoagulant
Dosage Form
Infusion
Packaging Type
Vial
Packaging
100ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tirofent 5 Infusion containing Tirofiban 5 mg is a potent antiplatelet medicine used in critical cardiac care settings. It helps in preventing platelet aggregation, reducing the risk of clot formation, and managing conditions like acute coronary syndrome.
Tirofiban works by inhibiting glycoprotein IIb/IIIa receptors on platelets, thereby preventing them from sticking together and forming clots. This mechanism ensures improved blood flow and reduces the chances of heart attack and related complications.
The infusion provides rapid and effective action in emergency and ICU settings, making it an essential part of advanced cardiac care protocols. It is widely used in patients undergoing angioplasty or those at high risk of thrombotic events.
With increasing incidence of cardiovascular diseases and demand for critical care medicines, this product has strong potential in hospital and institutional segments. Its high clinical importance, consistent usage in ICUs, and strong demand make it a valuable addition for expanding presence and driving growth in the cardiac care range.
Some patients may experience bleeding, bruising, nausea, headache, or dizziness. Rarely, serious bleeding events, thrombocytopenia, or allergic reactions may occur and require immediate medical attention.
Tirofent 5 Injection is indicated for the management of acute coronary syndromes such as unstable angina and non-ST elevation myocardial infarction (NSTEMI). It is also used in patients undergoing percutaneous coronary intervention (PCI) to prevent clot-related complications and improve cardiac outcomes.
This medicine should be administered under strict medical supervision, usually in a hospital setting. Patients with bleeding disorders, recent surgery, or uncontrolled hypertension should use this medication with caution. Regular monitoring of platelet count and coagulation parameters is essential during treatment.
Store in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children.
Composition : Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule
Composition : Atorvastatin (10mg) + Aspirin (75mg) Capsule
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.